What are the gradations of icterus (jaundice) and their corresponding bilirubin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Gradation of Icterus

Icterus follows a predictable cephalocaudal (head-to-toe) progression pattern, with jaundice appearing first in the face, then advancing to the chest and abdomen, and finally extending to the arms and legs—each stage indicating progressively higher bilirubin levels. 1

Anatomical Progression Zones

The clinical gradation system is based on the anatomical extent of visible jaundice:

  • Zone 1 (Face only): Jaundice limited to the face and head represents the earliest stage of icterus, typically corresponding to lower bilirubin levels 1

  • Zone 2 (Chest and abdomen): Progression of jaundice to the trunk indicates higher bilirubin levels than facial jaundice alone 1

  • Zone 3 (Arms and legs): Extension of jaundice to the extremities suggests more significant hyperbilirubinemia 1

  • Conjunctival icterus: When present, conjunctival icterus is consistently associated with total serum bilirubin (TSB) >14.9 mg/dL (255 μmol/L), typically placing infants in the 76th-95th percentile or >95th percentile on the Bhutani nomogram 2

Critical Assessment Principles

Visual estimation alone is unreliable and leads to errors, particularly in darkly pigmented infants—objective measurement with transcutaneous bilirubin (TcB) or TSB must be performed for any jaundice in the first 24 hours of life or when jaundice appears excessive. 1

  • TcB measurements generally provide values within 2-3 mg/dL of TSB for levels <15 mg/dL 1

  • Phototherapy "bleaches" the skin, rendering both visual assessment and TcB measurements unreliable during treatment 1

  • Jaundice assessment should occur at least every 8-12 hours in at-risk infants 1

Risk Stratification by Bilirubin Levels

The Bhutani hour-specific nomogram provides objective risk assessment based on measured bilirubin levels:

  • High-risk zone: 39.5% risk of developing TSB >95th percentile 1

  • High intermediate-risk zone: 12.9% risk of progression 1

  • Low intermediate-risk zone: 2.26% risk of progression 1

  • Low-risk zone: 0% risk of significant hyperbilirubinemia 1

Physiological vs. Pathological Thresholds

  • Physiological jaundice typically peaks at 5-6 mg/dL (86-103 μmol/L) at 72-96 hours of age and does not exceed 17-18 mg/dL (291-308 μmol/L) 3

  • Levels may not peak until seven days of age in Asian infants or those born at 35-37 weeks' gestation 3

  • Bilirubin levels exceeding these physiological ranges are considered pathological and require evaluation 3

Common Pitfalls to Avoid

  • Never rely on visual assessment alone, especially in infants with darker skin pigmentation 1

  • Do not use TcB measurements during or immediately after phototherapy 1

  • Any jaundice appearing in the first 24 hours of life mandates immediate objective measurement, as this is never physiological 1

  • Conjunctival icterus should trigger immediate TSB measurement and evaluation, as it indicates clinically significant hyperbilirubinemia 2

References

Guideline

Clinical Gradation of Icterus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Icterus Neonatorum in Near-Term and Term Infants: An overview.

Sultan Qaboos University medical journal, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.